Zachary Roberts
Chief Medical Officer, Instil Bio, Inc.
Companies
- Allogene Therapeutics, Inc.Chief executive officer Jul 6, 2026 to now1
- Allogene Therapeutics, Inc.President Jul 6, 2026 to now1
- Allogene Therapeutics, Inc.EVP of R&D Jan 9, 2023 to now2
- Instil Bio, Inc.Chief Medical Officer Mar 18, 2021 to Mar 7, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Allogene Therapeutics, Inc. ALLO581,166 shares4$745.1K at $1.28Feb 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 2, 2026Sold 35,700 shares at $1.77 of Allogene Therapeutics, Inc.4
- Jan 21, 2026Sold 26,269 shares at $1.56 of Allogene Therapeutics, Inc.5
- Feb 3, 2025Sold 18,832 shares at $1.70 of Allogene Therapeutics, Inc.6
- Jan 24, 2025Granted 173,913 shares of Allogene Therapeutics, Inc.7
- Jan 21, 2025Sold 27,199 shares at $1.78 of Allogene Therapeutics, Inc.8
- Jan 25, 2024Granted 140,000 shares of Allogene Therapeutics, Inc.9
- Jan 22, 2024Shares withheld for tax 24,690 shares at $3.17 of Allogene Therapeutics, Inc.10
- Mar 22, 2023Granted 148,035 shares of Allogene Therapeutics, Inc.11
- Jan 20, 2023Granted 251,908 shares of Allogene Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jan 23, 2026
- 6SEC EDGARForm 4 filed Feb 5, 2025
- 7SEC EDGARForm 4 filed Jan 28, 2025
- 8SEC EDGARForm 4 filed Jan 23, 2025
- 9SEC EDGARForm 4 filed Jan 31, 2024
- 10SEC EDGARForm 4 filed Jan 24, 2024
- 11SEC EDGARForm 4 filed Mar 24, 2023
- 12SEC EDGARForm 4 filed Jan 24, 2023